PATENT CLAIM ANALYSIS

Application Number: 16006548
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability, solubility, or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 8):
The oral dosage form of  claim 7 , wherein the proton pump inhibitor is esomeprazole.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 94.0
- Lexical Diversity: 1.39474
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15988104', '16006642', '16006692', '15984055', '15902770']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8065779981064087
- 35 USC 102 Novelty (BERT): 0.5303452037439509
- Combined Prediction Score: 0.778954718670163
- Mean Citation Score: 335.54680999999994
- Max Citation Score: 338.02664
- Similarity Product: 213.84357380285263

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test